Stifel on Treace Medical Concepts Inc (TMCI): 'directionally-encouraged' by targets despite sales decline

April 9, 2026 11:22 AM EDT Send to a Friend
Stifel analyst Rick Wise reiterated a Hold rating and $3.00 price target on Treace Medical Concepts Inc (NASDAQ: TMCI)The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login